Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction

Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1749-1756. doi: 10.1007/s10096-017-2988-6. Epub 2017 Apr 28.

Abstract

How circulating inflammatory mediators change upon sepsis progression has not been studied. We studied the follow-up changes of circulating vasoactive peptides and cytokines until the improvement or the worsening of a patient and progression into specific organ dysfunctions. In a prospective study, concentrations of tumor necrosis factor-alpha (TNFα), interleukin (IL)-6, IL-8, IL-10, interferon-gamma (IFNγ), endocan and angiopoietin-2 (Ang-2) were measured in serum by an enzyme immunoassay in 175 patients at baseline; this was repeated within 24 h upon progression into new organ dysfunction (n = 141) or improvement (n = 34). Endocan and Ang-2 were the only parameters that were significantly increased among patients who worsened. Any increase of endocan was associated with worsening with odds ratio 16.65 (p < 0.0001). This increase was independently associated with progression into acute respiratory distress syndrome (ARDS) as shown after logistic regression analysis (odds ratio 2.91, p: 0.002). Changes of circulating cytokines do not mediate worsening of the critically ill patients. Instead endocan and Ang2 are increased and this may be interpreted as a key-playing role in the pathogenesis of ARDS and septic shock. Any increase of endocan is a surrogate of worsening of the clinical course.

Keywords: Acute Kidney Injury; Acute Lung Injury; Organ Dysfunction; Septic Shock; Systemic Inflammatory Response Syndrome.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cytokines / blood
  • Disease Progression
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Neoplasm Proteins / blood*
  • Organ Dysfunction Scores
  • Prospective Studies
  • Proteoglycans / blood*
  • Respiratory Distress Syndrome / pathology
  • Sepsis / pathology*
  • Serum / chemistry
  • Vesicular Transport Proteins / blood

Substances

  • Cytokines
  • ESM1 protein, human
  • Neoplasm Proteins
  • Proteoglycans
  • VPS51 protein, human
  • Vesicular Transport Proteins